Previous Article | Next Article 
Molecular and Cellular Biology, August 1999, p. 5486-5494, Vol. 19, No. 8
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Human TAFII55 Interacts with the Vitamin
D3 and Thyroid Hormone Receptors and with Derivatives of
the Retinoid X Receptor That Have Altered Transactivation
Properties
Anne-Claire
Lavigne,
Gabrielle
Mengus,
Yann-Gaël
Gangloff,
Jean-Marie
Wurtz, and
Irwin
Davidson*
Institut de Génétique et de
Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Illkirch
Cédex, C.U. de Strasbourg, France
Received 9 October 1998/Returned for modification 14 December
1998/Accepted 14 May 1999
We have identified novel interactions between the human
(h)TATA-binding protein-associated factor TAFII55 and the
ligand-binding domains (LBDs) of the nuclear receptors for vitamin
D3 (VDR) and thyroid hormone (TR
). Following expression
in Cos cells, hTAFII55 interacts with the VDR and TR
LBDs in a ligand-independent manner whereas no interactions with the
retinoid X receptors (RXRs) or with other receptors were observed.
Deletion mapping indicates that hTAFII55 interacts with a
40-amino-acid region spanning
-helices H3 to H5 of the VDR and TR
LBDs but not with the equivalent highly related region of RXR
.
TAFII55 also interacts with chimeric receptors in which the
H3-to-H5 region of RXR
has been replaced with that of the VDR or
TR
. Furthermore, replacement of two single amino acids of the RXR
LBD with their VDR counterparts allows the RXR
LBD to interact with
hTAFII55 while the corresponding double substitution allows
a much stronger interaction. In transfection experiments, the single
mutated RXR
LBDs activate transcription to fivefold higher levels
than wild-type RXR
while the double mutation activates transcription
to a level comparable to that observed with the VDR. There is therefore
a correlation between the ability of the modified RXRs to interact with
hTAFII55 and transactivation. These results strongly
suggest that the TAFII55 interactions with the modified RXR
LBDs modulate transcriptional activation.
*
Corresponding author. Mailing address: Institut de
Génétique et de Biologie Moléculaire et Cellulaire,
CNRS/INSERM/ULP, B.P. 163-67404, Illkirch Cédex, C.U. de
Strasbourg, France. Phone: 33 3 88 65 34 40 (45). Fax: 33 3 88 65 32 01. E-mail: irwin{at}titus.u-strasbg.fr.

Present address: EMBL, 69012, Heidelberg,
Germany.
Molecular and Cellular Biology, August 1999, p. 5486-5494, Vol. 19, No. 8
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dreijerink, K. M.A., Mulder, K. W., Winkler, G. S., Hoppener, J. W.M., Lips, C. J.M., Timmers, H.Th. M.
(2006). Menin Links Estrogen Receptor Activation to Histone H3K4 Trimethylation.. Cancer Res.
66: 4929-4935
[Abstract]
[Full Text]
-
Nagpal, S., Na, S., Rathnachalam, R.
(2005). Noncalcemic Actions of Vitamin D Receptor Ligands. Endocr. Rev.
26: 662-687
[Abstract]
[Full Text]
-
Sutton, A. L. M., MacDonald, P. N.
(2003). Vitamin D: More Than a "Bone-a-Fide" Hormone. Mol. Endocrinol.
17: 777-791
[Abstract]
[Full Text]
-
Pointud, J.-C., Mengus, G., Brancorsini, S., Monaco, L., Parvinen, M., Sassone-Corsi, P., Davidson, I.
(2003). The intracellular localisation of TAF7L, a paralogue of transcription factor TFIID subunit TAF7, is developmentally regulated during male germ-cell differentiation. J. Cell Sci.
116: 1847-1858
[Abstract]
[Full Text]
-
Zhou, T., Chiang, C.-M.
(2002). Sp1 and AP2 regulate but do not constitute TATA-less human TAFII55 core promoter activity. Nucleic Acids Res
30: 4145-4157
[Abstract]
[Full Text]
-
Benecke, A., Gaudon, C., Garnier, J.-M., vom Baur, E., Chambon, P., Losson, R.
(2002). ADA3-containing complexes associate with estrogen receptor alpha. Nucleic Acids Res
30: 2508-2514
[Abstract]
[Full Text]
-
Silkov, A., Wolstein, O., Shachar, I., Dikstein, R.
(2002). Enhanced Apoptosis of B and T Lymphocytes in TAFII105 Dominant-negative Transgenic Mice Is Linked to Nuclear Factor-kappa B. J. Biol. Chem.
277: 17821-17829
[Abstract]
[Full Text]
-
Tocchini-Valentini, G., Rochel, N., Wurtz, J. M., Mitschler, A., Moras, D.
(2001). Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc. Natl. Acad. Sci. USA
98: 5491-5496
[Abstract]
[Full Text]
-
Hernández-Hernández, A., Ferrús, A.
(2001). Prodos Is a Conserved Transcriptional Regulator That Interacts with dTAFII16 in Drosophila melanogaster. Mol. Cell. Biol.
21: 614-623
[Abstract]
[Full Text]
-
Matangkasombut, O., Buratowski, R. M., Swilling, N. W., Buratowski, S.
(2000). Bromodomain factor 1 corresponds to a missing piece of yeast TFIID. Genes Dev.
14: 951-962
[Abstract]
[Full Text]
-
Mengus, G., Gangloff, Y.-G., Carre, L., Lavigne, A.-C., Davidson, I.
(2000). The Human Transcription Factor IID Subunit Human TATA-binding Protein-associated Factor 28 Interacts in a Ligand-reversible Manner with the Vitamin D3 and Thyroid Hormone Receptors. J. Biol. Chem.
275: 10064-10071
[Abstract]
[Full Text]
-
Jurutka, P. W., Remus, L. S., Whitfield, G. K., Thompson, P. D., Hsieh, J.-C., Zitzer, H., Tavakkoli, P., Galligan, M. A., Dang, H. T. L., Haussler, C. A., Haussler, M. R.
(2000). The Polymorphic N Terminus in Human Vitamin D Receptor Isoforms Influences Transcriptional Activity by Modulating Interaction with Transcription Factor IIB. Mol. Endocrinol.
14: 401-420
[Abstract]
[Full Text]
-
Andel III, F., Ladurner, A. G., Inouye, C., Tjian, R., Nogales, E.
(1999). Three-Dimensional Structure of the Human TFIID-IIA-IIB Complex. Science
286: 2153-2156
[Abstract]
[Full Text]
-
Rojo-Niersbach, E., Furukawa, T., Tanese, N.
(1999). Genetic Dissection of hTAFII130 Defines a Hydrophobic Surface Required for Interaction with Glutamine-rich Activators. J. Biol. Chem.
274: 33778-33784
[Abstract]
[Full Text]
-
Zhou, T., Chiang, CM
(2001). The Intronless and TATA-less Human TAFII55 Gene Contains a Functional Initiator and a Downstream Promoter Element. J. Biol. Chem.
276: 25503-25511
[Abstract]
[Full Text]